Brief: Greenwich Lifesciences Announces Expansion Of Flamingo-01 Clinical Trial To Ireland
18/09/2025 11:50
Greenwich Lifesciences Inc GLSI.O: GREENWICH LIFESCIENCES ANNOUNCES EXPANSION OF FLAMINGO-01 CLINICAL TRIAL TO IRELAND GREENWICH LIFESCIENCES : CO'S APPLICATION TO EUROPEAN REGULATORS FORMALLY APPROVED, ADDING IRELAND AS APPROVED COUNTRY IN FLAMINGO-01 Source text: ID:nGNXtmh1w Further company coverage: GLSI.O
Recent news on Greenwich Lifesciences
See all newsFactbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine
Greenwich Lifesciences Inc reports results for the quarter ended June 30 - Earnings Summary
Greenwich Lifesciences Inc expected to post a loss of 33 cents a share - Earnings Preview
Brief: Greenwich Lifesciences Announces Approval To Expand FLAMINGO-01 Into The United Kingdom
U.S. STOCKS ON THE MOVE-Yum Brands, AMD, Nuvation Bio